- Home
- ABT vs MRK Comparison
ABT vs MRK Comparison
Compare ABT & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABT
- MRK
- Stock Information
- Founded
- ABT 1888
- MRK 2000
- Country
- ABT United States
- MRK United States
- Employees
- ABT N/A
- MRK N/A
- Industry
- ABT Medical/Dental Instruments
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ABT Health Care
- MRK Health Care
- Exchange
- ABT Nasdaq
- MRK Nasdaq
- Market Cap
- ABT 231.5B
- MRK 218.8B
- IPO Year
- ABT N/A
- MRK N/A
- Fundamental
- Price
- ABT $125.72
- MRK $83.50
- Analyst Decision
- ABT Strong Buy
- MRK Buy
- Analyst Count
- ABT 18
- MRK 15
- Target Price
- ABT $146.61
- MRK $105.14
- AVG Volume (30 Days)
- ABT 6.3M
- MRK 10.0M
- Earning Date
- ABT 10-15-2025
- MRK 10-30-2025
- Dividend Yield
- ABT 1.86%
- MRK 3.74%
- EPS Growth
- ABT 141.96
- MRK 20.41
- EPS
- ABT 7.96
- MRK 6.49
- Revenue
- ABT $43,843,000,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- ABT $7.56
- MRK $1.76
- Revenue Next Year
- ABT $7.78
- MRK $5.11
- P/E Ratio
- ABT $15.63
- MRK $13.35
- Revenue Growth
- ABT 6.37
- MRK 1.82
- 52 Week Low
- ABT $110.86
- MRK $73.31
- 52 Week High
- ABT $141.23
- MRK $105.11
- Technical
- Relative Strength Index (RSI)
- ABT 37.39
- MRK 42.56
- Support Level
- ABT $124.12
- MRK $86.91
- Resistance Level
- ABT $128.45
- MRK $88.30
- Average True Range (ATR)
- ABT 2.54
- MRK 1.43
- MACD
- ABT -0.45
- MRK -0.25
- Stochastic Oscillator
- ABT 17.35
- MRK 5.90
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).